Autoantibodies against P29ING4 are associated with complex regional pain syndrome N. T. BaerleckenR. GaulkeM. Bernateck Original Article Open access 01 February 2020 Pages: 461 - 468
Retained or altered expression of major histocompatibility complex class I in patient-derived xenograft models in breast cancer In Hye SongYoung-Ae KimHee Jin Lee Original Article 03 January 2020 Pages: 469 - 477
A high-risk laboratory profile of antiphospholipid antibodies and thrombosis is associated with a large number of extra-criteria manifestations in obstetric antiphospholipid syndrome Sebastián UdryJosé Omar LatinoGabriela de Larrañaga Original Article 23 December 2019 Pages: 478 - 485
CD226 attenuates Treg suppressive capacity via CTLA-4 and TIGIT during EAE Ning WangShuang LiangLihua Chen Original Article 09 January 2020 Pages: 486 - 496
Promotion on NLRC5 upregulating MHC-I expression by IFN-γ in MHC-I–deficient breast cancer cells Ming-Zhen ZhaoYu SunLi-Xin Sun Original Article 03 January 2020 Pages: 497 - 504
Blockade of TLR4 using TAK-242 (resatorvid) enhances anti-cancer effects of chemotherapeutic agents: a novel synergistic approach for breast and ovarian cancers Bahareh KashaniZahra ZandiSeyed H. Ghaffari Original Article 05 February 2020 Pages: 505 - 516